omniture
LUNIT INC

Latest News

Lunit Announces Partnership with the National Cancer Institute to Advance AI-Powered Biomarker Research

Collaboration to apply Lunit's AI technologies across NCI's broad spectrum of cancer studies, aimin...

2025-03-31 21:00 2419

Lunit to Present AI Study on EGFR Mutation Prediction in NSCLC at AACR 2025 in Collaboration with AstraZeneca

AI-powered model predicts EGFR mutations from H&E-stained slides, demonstrating robust performance ...

2025-03-26 21:00 2231

Lunit Secures Multi-Year Contract with UAE's Largest Healthcare Network to Power National AI Breast Cancer Screening Program

Strategic agreement to deploy Lunit INSIGHT MMG across SEHA's extensive healthcare network, analyzi...

2025-03-18 21:00 3136

World's First Large-Scale, Multicenter Prospective Study in Single-Reading Mammography Confirms Lunit AI Boosts Cancer Detection

Prospective study finds Lunit AI increases cancer detection by 13.8% in single-reader settings with...

2025-03-10 21:00 2599

Lunit Expands Partnership with Saudi Arabia's Largest Medical Group to Deploy AI Chest X-Ray Solution

Following last year's success, Lunit secures a second contract with Dr. Sulaiman Al Habib Medical G...

2025-03-06 22:00 3552

Lunit Achieves Milestone at ECR 2025: 13 Oral Presentations Among 15 AI Studies, Demonstrating Unmatched Clinical Impact

* Lunit to present 15 studies, with an unprecedented 13 accepted as oral presentations, marking a...

2025-02-27 22:00 2609

Lunit Announces Leadership Transition at Volpara: Craig Hadfield Appointed CEO

SEOUL, South Korea and WELLINGTON, New Zealand, Feb. 26, 2025 /PRNewswire/ -- Lunit (KRX:328130.KQ)...

2025-02-26 22:00 2636

Lunit Partners with SITC to Launch Exclusive Research Program Featuring Advanced AI Technology for SITC Members

Lunit SCOPE® IO now available to SITC members for AI-powered TME profiling, in a collaborative effo...

2025-02-03 22:00 3403

Lunit AI Enhances Precision in Predicting Outcomes for HER2-Targeted Therapy in Metastatic Colorectal Cancer - new study published in JCO Precision Oncology

Newly published study in collaboration with Japan's NCCHE reveals how AI-powered HER2 and tumor mic...

2025-01-23 22:00 4282

New Lunit Study Demonstrates Universal AI Model for Analysis of Immunohistochemistry Images

Research in npj Precision Oncology highlights multi-cohort training approach and accurate analysis ...

2024-12-12 22:08 2571

Lunit Marks Go-Live in Groundbreaking National AI Cancer Screening Program in BreastScreen NSW

Lunit INSIGHT MMG integrated into the clinical workflow of Australia's BreastScreen New South Wales...

2024-12-09 22:00 2543

Lunit and Volpara Unveiled Unified Ecosystem at RSNA 2024 to Transform Global Cancer Care

Lunit and Volpara revealed a unified Ecosystem at RSNA 2024, featuring AI-powered cancer risk predi...

2024-12-05 22:07 2769

Real-World Validation: Lunit AI Proven Successful in 1-Year Breast Cancer Screening Deployment

Follow-up to ScreenTrustCAD presented at RSNA 2024 highlights 1-year post-AI adoption success in im...

2024-12-02 22:00 2375

Lunit Inks Partnership with Salud Digna to Advance AI in Medical Imaging

* AI-powered chest X-ray and mammography analysis solutions to be deployed across one ofMexico's ...

2024-11-27 22:00 2642

Lunit to Showcase Research Contributions at RSNA 2024 with Record-Breaking 20 Abstracts

Twenty studies validate AI performance across diverse populations and clinical settings, including ...

2024-11-25 22:00 1795

Lunit Announces Collaboration with AstraZeneca to Develop AI-Powered Digital Pathology Risk Assessment Tools for NSCLC

Collaboration to harness Lunit SCOPE Genotype Predictor for rapid and convenient prediction of non-...

2024-11-18 22:00 2462

Lunit Partners with VIDI Group to Deliver AI-Powered Mammography to France's Largest Radiology Network

Agreement to make Lunit INSIGHT MMG accessible to over 400 sites across France SEOUL, South Korea, ...

2024-11-13 22:00 2475

Lunit Shows Promise of AI in Predicting Immunotherapy Response for Rare Cancer Patients at SITC 2024

Study reveals potential of AI-powered tumor microenvironment assessment in predicting treatment out...

2024-11-08 22:00 3625

Lunit AI Predicts Breast Cancer Risk Up to 6 Years in Advance

* Two new studies show Lunit INSIGHT MMG cuts radiologist workload by 50% in a double reading env...

2024-10-23 21:00 2851

Lunit to Present AI-Analyzed Immune Phenotype Study as Immunotherapy Response Predictor for Advanced Gastric Cancer at ESMO Congress 2024

* Lunit SCOPE IO® demonstrates potential to assess immune phenotype as an AI-powered biomarker fo...

2024-09-10 21:00 2472
12345 ... 7